| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |